Equities

Shanghai ZJ Bio-Tech Co Ltd

688317:SHH

Shanghai ZJ Bio-Tech Co Ltd

Actions
Health CareMedical Equipment and Services
  • Price (CNY)14.20
  • Today's Change-4.06 / -22.23%
  • Shares traded1.47m
  • 1 Year change-38.79%
  • Beta0.8882
Data delayed at least 15 minutes, as of Sep 13 2024 08:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of CNY
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments2,7693,1472,936
Total Receivables, Net127238294
Total Inventory254504299
Prepaid expenses162023
Other current assets, total0.210.250.35
Total current assets3,1663,9103,553
Property, plant & equipment, net747686586
Goodwill, net5.405.405.40
Intangibles, net6.066.846.57
Long term investments10912296
Note receivable - long term------
Other long term assets------
Total assets4,0744,7444,255
LIABILITIES
Accounts payable121318237
Accrued expenses7510278
Notes payable/short-term debt000
Current portion long-term debt/capital leases2.812.94--
Other current liabilities, total3810194
Total current liabilities237524409
Total long term debt4.645.690
Total debt7.458.630
Deferred income tax0.452.174.54
Minority interest------
Other liabilities, total7.591214
Total liabilities249543427
SHAREHOLDERS EQUITY
Common stock195195195
Additional paid-in capital2,1502,1502,150
Retained earnings (accumulated deficit)1,5871,9531,458
Treasury stock - common(102)(102)--
Unrealized gain (loss)(6.56)3.18--
Other equity, total2.051.5624
Total equity3,8254,2003,827
Total liabilities & shareholders' equity4,0744,7444,255
Total common shares outstanding192192195
Treasury shares - common primary issue2.552.550
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.